Gillian C. Ivers-Read

2020

In 2020, Gillian C. Ivers-Read earned a total compensation of $1.4M as EVP and Chief Regulatory Officer at Clovis Oncology, a 49% decrease compared to previous year.

Compensation breakdown

Bonus$234,448
Salary$479,674
Stock Awards$613,460
Other$27,820
Total$1,355,402

Ivers-Read received $613.5K in stock awards, accounting for 45% of the total pay in 2020.

Ivers-Read also received $234.4K in bonus, $479.7K in salary and $27.8K in other compensation.

Rankings

In 2020, Gillian C. Ivers-Read's compensation ranked 7,294th out of 13,090 executives tracked by ExecPay. In other words, Ivers-Read earned more than 44.3% of executives.

ClassificationRankingPercentile
All
7,294
out of 13,090
44th
Division
Manufacturing
3,052
out of 5,620
46th
Major group
Chemicals And Allied Products
1,228
out of 2,253
46th
Industry group
Drugs
1,061
out of 1,953
46th
Industry
Pharmaceutical Preparations
794
out of 1,458
46th

Pay ratio

Gillian C. Ivers-Read's Pay$1,355,402
Median Employee's Pay$230,943
Pay Ratio

6

to 1

In 2020, the annual total compensation of Gillian C. Ivers-Read was $1,355,402.

The annual total compensation of the median employee at Clovis Oncology was $230,943.

The ratio of Gillian C. Ivers-Read's pay to the pay of median employee was therefore 6 to one.

Source: SEC filing on April 28, 2021.

Ivers-Read's colleagues

We found four more compensation records of executives who worked with Gillian C. Ivers-Read at Clovis Oncology in 2020.

2020

Patrick Mahaffy

Clovis Oncology

Chief Executive Officer

2020

Lindsey Rolfe

Clovis Oncology

Chief Medical Officer

2020

Paul Gross

Clovis Oncology

General Counsel

2020

Daniel Muehl

Clovis Oncology

Chief Financial Officer

News

You may also like